Market Overview

UPDATE: Goldman Sachs Reduces PT to $16 on NuVasive on Sales Outlook

Share:
Related NUVA
82 Biggest Movers From Yesterday
66 Stocks Moving In Wednesday's Mid-Day Session
NuVasive launches interbody implant in U.S. for ALIF spine surgery (Seeking Alpha)

Goldman Sachs reiterated its Neutral rating on NuVasive (NASDAQ: NUVA) and lowered its price target from $17 to $16.

Goldman Sachs commented, "NUVA shares reacted well to earnings (+12% mid-day vs. the Russell 2000 -0.2%), on management initiatives to reverse negative share trends (the stock was down 44% since the 10/3 pre-announcement as of the 10/23 close, vs -3% for the Russell 2000). Early trends are favorable, with new account capture already realized. It will, however, take time for new reps to ramp productivity, deferring a material improvement in overall sales growth; this is reflected in our revised model that calls for +1% in 1H13 and +9% in 2H13."

NuVasive closed at $12.65 on Tuesday.

Latest Ratings for NUVA

DateFirmActionFromTo
Oct 2018Morgan StanleyMaintainsEqual-WeightEqual-Weight
Oct 2018BMO CapitalMaintainsMarket PerformMarket Perform
Oct 2018Canaccord GenuityMaintainsBuyBuy

View More Analyst Ratings for NUVA
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (NUVA)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
LXFTKeyBancDowngrades0.0
CPAImperial CapitalDowngrades68.0
PRMWImperial CapitalInitiates Coverage On18.0
TGTKeyBancInitiates Coverage On110.0
QCOMMorgan StanleyUpgrades0.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

UPDATE: KeyBanc Capital Markets Downgrades Air Products & Chemicals to Hold, Removes PT

UPDATE: BMO Capital Markets Reiterates Market Perform Rating, Raises PT on Juniper Networks